Bloomer Biotech Investment Advisors (BBIA)
BBIA invests in the most promising, undervalued biotechnology companies
BBIA sees opportunities where others don't focus. Having closely followed scientific and technological progress, the company is well suited to accurately envision the future arc of scientific, technological, business, and financial development.
Simply put, biotechnology is the merging of medicine, science, and technology. The term “biotechnology” was believed to have been first used by Karl Ereky, a Hungarian engineer, and was defined as part of the Convention on Biological Diversity as, “any technological application that uses biological systems or living organisms or derivatives thereof to make or modify the process or products for specific use.”
Biotech has been around for thousands of years as part of agriculture, medicine, and food production. Over the last century, we have seen biotechnology become an integral part of significant advances in all of these areas. The field is now seeing exponential growth and has enabled developments that only a short time ago seemed impossible. These new and exciting areas include genomics, immunology, drug delivery systems, drug therapies, diagnostic testing, pollution controls, tissue regeneration, and even organ growth.
Visit website: https://bloomerbiotech.com/
Details last updated 08-May-2022